ETF MANAGERS GROUP, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2023$148,386
-11.1%
9,004
-29.9%
0.01%0.0%
Q3 2022$167,000
-7.2%
12,846
-1.0%
0.01%0.0%
Q2 2022$180,000
-20.4%
12,974
-17.2%
0.01%0.0%
Q1 2022$226,000
-41.5%
15,660
-44.9%
0.01%
-37.5%
Q4 2021$386,000
-21.2%
28,417
-5.5%
0.01%
-11.1%
Q3 2021$490,000
+34.2%
30,065
+38.5%
0.01%
+50.0%
Q2 2021$365,000
-4.2%
21,703
+4.5%
0.01%
-14.3%
Q1 2021$381,000
+3.0%
20,773
+2.0%
0.01%
-12.5%
Q4 2020$370,000
+5.7%
20,368
+5.6%
0.01%
-27.3%
Q3 2020$350,000
+167.2%
19,297
+166.3%
0.01%
+120.0%
Q2 2020$131,0007,2450.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders